<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01006486</url>
  </required_header>
  <id_info>
    <org_study_id>COEP376/09</org_study_id>
    <nct_id>NCT01006486</nct_id>
  </id_info>
  <brief_title>Outcomes of an Anticoagulation Clinic in an University Hospital</brief_title>
  <official_title>Evaluation of Impact of the Implantation of an Anticoagulation Clinic in an University Hospital in Brazil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinical trial designed to compare the oral anticoagulation control obtained by an
      anticoagulation clinic and the usual medical care in Chagas and Non-Chagas disease patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Randomized, Crossover, Clinical Trial performed to compare the results of oral
      anticoagulation for Chagas and non-Chagas disease patients treated at an anticoagulation
      clinic and by the usual clinical practice. The primary endpoint was the time that the
      International Normalized Ratio (INR) was in the therapeutic range and the secondary endpoints
      were thromboembolic/haemorragic events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time in therapeutic range</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemorrhagic events</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thromboembolic events</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Cardiopathy</condition>
  <condition>Chagas Disease</condition>
  <condition>Hemorrhage</condition>
  <condition>Thrombosis</condition>
  <arm_group>
    <arm_group_label>Anticoagulation clinic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anticoagulation clinic, including all procedures related to a standardized use of coumarins.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard use of coumarins, as prescribed by their physicians.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anticoagulation clinic</intervention_name>
    <description>Patients randomized to this arm will be cared at an anticoagulation clinic, with educational measures and standardized procedures related to the use of coumarins.</description>
    <arm_group_label>Anticoagulation clinic</arm_group_label>
    <other_name>Implementation of a health service</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard anticoagulation care</intervention_name>
    <description>Patients randomized to this arm will be cared by their physician, with standard care. No standardized protocol of the use of coumarins will be established.</description>
    <arm_group_label>Standard care</arm_group_label>
    <other_name>Implementation of a health service</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatients

          -  Chagas and non-Chagas disease patients

          -  Any indication for chronic treatment with warfarin

          -  Anticoagulation for at least 30 days.

        Exclusion Criteria:

          -  Refusal to participate in the study;

          -  Use of phenprocoumon;

          -  Expectation of treatment lower than 1 year;

          -  Difficulties to attend medical visits;

          -  Participation in other prospective clinical study involving anticoagulation care
             during the study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio L Ribeiro, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manoel Otávio C Rocha, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Auxiliadora P Martins, Pharmacist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cibele C César, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel D Ribeiro, Physician</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vandack Nobre, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal University of Minas Gerais</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30130-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2009</study_first_submitted>
  <study_first_submitted_qc>November 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2009</study_first_posted>
  <last_update_submitted>October 24, 2011</last_update_submitted>
  <last_update_submitted_qc>October 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Antonio Luiz Pinho Ribeiro</investigator_full_name>
    <investigator_title>Professor Antonio Luiz Pinho Ribeiro</investigator_title>
  </responsible_party>
  <keyword>Oral anticoagulants</keyword>
  <keyword>Warfarin</keyword>
  <keyword>Anticoagulation clinic</keyword>
  <keyword>Thrombosis</keyword>
  <keyword>Hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Chagas Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

